Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                CTP Newsroom

CTP Newsroom

                        Feature Stories Home
          Tobacco Products
          CTP Newsroom
          FDA’s Proposed New Requirements for Tobacco Product Manufacturing Practices - 04/12/2023CTP Newsroom Public Hearing
    Event Title
              FDA’s Proposed New Requirements for Tobacco Product Manufacturing Practices


                  April 12, 2023

  Scheduled

    
  Share
    Post
    Linkedin

    Email
    PrintDate:
          
  


     
           

April 12, 2023
                
  Organized By: 
      Organizer
          Center for Tobacco Products

 





**On this page:**

Session Recording
	Public Oral Hearing ObjectiveSession Recording



Transcript: Oral Hearing on FDA’s Proposed New Requirements for Tobacco Product ManufacturersPublic Oral Hearing Objective

FDA held a public oral hearing on April 12, 2023, to provide stakeholders with an opportunity to share their comments on the proposed rule: “Requirements for Tobacco Product Manufacturing Practice.”

FDA proposed new requirements for tobacco product manufacturers regarding the manufacture, design, packing, and storage of their products. These proposed requirements would help protect public health by, among other things, minimizing or preventing contamination and limiting additional risks by ensuring product consistency. The public oral hearing allowed FDA to gather additional comments on the proposed rule from stakeholders, including industry, the scientific community, advocacy groups, and the public.

FDA’s aim was to make this hearing a transparent and inclusive opportunity to hear a range of ideas and perspectives from all interested parties. Groups and organizations were asked to select a single spokesperson to help FDA hear as many different perspectives as possible. No presentation materials or slides were used during the hearing.

Live closed captioning and ASL interpreters  were provided during the listening session. The transcript and recordingare now available and are accessible through the dockets as well as on this page.

This public oral hearing featured the following participants:

Opening Moderator 
	Necola Staples, MBA Supervisory Health Communications Specialist, Office of Health Communications and Education, Center for Tobacco Products (CTP), FDA
	Presiding Officer 
	Dr. Brian King, PhD, MPH, Director, CTP, FDA
	Panelists
	Mr. Matthew Brenner, J.D., Senior Regulatory Counsel, Office of Regulations, CTP, FDA
		Mr. Emil Wang, J.D., Rear Admiral, U.S. Public Health Service, Senior Regulatory Counsel and Senior Advisor for Manufacturing and Regulatory Policy, Office of Compliance and Enforcement, CTP, FDA
		Dr. Dale Slavin, PhD, Supervisory Science Policy Analyst, Branch Director, Science Policy Branch, Office of Science, CTP, FDA
		Dr. Matthew Walters, PhD, MPH, Commander, U.S. Public Health Service, Deputy Division Director, Division of Product Science, Office of Science, CTP, FDA
		Ms. Diana Kaneva, Associate Chief Counsel, Office of the Chief Counsel, OC, FDA
		Mr. Dylan Leischow, M.A., Economist, Office of Regulations, CTP, FDA
		Dr./Ms./Mr. Cristina McLaughlin (FDA OEA), Office of Economic Analysis, FDA

                                                                                  Content current as of:
      05/11/2023
         
                   
Regulated Product(s)
		 TobaccoMore Meetings,
      Conferences, and
      Workshops
        
        CTP Newsroom

          
                        Feature Stories
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop